Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway

Archives of Toxicology

Volumn 85, Issue 3, 2011, Pages 199-207

  Mizuno, Katsuhiko ^a   Toyoda, Yasuyuki ^a   Fukami, Tatsuki ^a   Nakajima, Miki ^a   Yokoi, Tsuyoshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Hepatotoxicity; IL 8; Mebendazole; THP 1 cell; TNF

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; CHEMOKINE; CYTOKINE; FENBENDAZOLE; INTERLEUKIN 8; MEBENDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIBENDAZOLE; PRAZIQUANTEL; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CELL STRAIN; CELL STRAIN THP 1; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION;

ANTHRACENES; ANTINEMATODAL AGENTS; CELL LINE, TUMOR; CELLS, CULTURED; CHEMOKINES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMIDAZOLES; INTERLEUKIN-8; MEBENDAZOLE; MITOGEN-ACTIVATED PROTEIN KINASES; MONOCYTES; PYRIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954417943     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-010-0584-y     Document Type: Article

References (30)

1. RW Ammann J Eckert 1996 Cestodes. Echinococcus Gastroenterol Clin North Am 25 655 689 1:STN:280:DyaK2s%2Fhs1Cisg%3D%3D 10.1016/S0889-8553(05)70268-5 8863045 (Pubitemid 26335828)
2. M Baggiolini B Dewald B Moser 1994 Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines Adv Immunol 55 97 179 1:CAS:528: DyaK2cXktlamtr8%3D 10.1016/S0065-2776(08)60509-X 8304236
3. H Bagheri E Simiand JL Montastruc JF Magnaval 2004 Adverse drug reactions to anthelmintics Ann Pharmacother 38 383 388 1:CAS:528:DC%2BD2cXitFSlt7k%3D 10.1345/aph.1D325 14749518 (Pubitemid 38235325)
4. A Bekhti J Pirotte 1987 Hepatotoxicity of mebendazole, Relationship with serum concentrations of the drug Gastroenterol Clin Biol 11 701 703 1:STN:280:DyaL1c%2FosVajug%3D%3D 3692093 (Pubitemid 18000668)
5. CA Bradham J Plümpe MP Manns DA Brenner C Trautwein 1998 Mechanisms of hepatic toxicity. I. TNF-induced liver injury Am J Physiol 275 G387 G392 1:CAS:528:DyaK1cXmtFSqtb8%3D 9724248
6. K-T Chen S-J Twu H-J Chen R-S Lin 2003 Outbreak of Steravens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan Am J Public Health 93 489 492 10.2105/AJPH.93.3.489 12604501 (Pubitemid 36255198)
7. Choi GY, Yang HW, Cho SH, Kang DW, Go H, Lee WC, Lee YJ, Jung SH, Kim AN, Cha SW (2008) Acute drug-induced hepatitis caused by albendazole. J Korean Med Sci 23:903-905. doi: 10.3346/jkms.2008.23.5.903
8. I Colle S Naegels A Hoorens M Hautekeete 1999 Granulomatous hepatitis due to mebendazole J Clin Gastroenterol 28 44 45 1:STN:280:DyaK1M7htlOjsQ%3D%3D 10.1097/00004836-199901000-00010 9916665 (Pubitemid 29011593)
9. N Corti A Heck K Rentsch W Zingg A Jetter B Stieger C Pauli-Magnus 2009 Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers Eur J Clin Pharmacol 65 999 1006 1:CAS:528:DC%2BD1MXhtFCjurnL 10.1007/s00228-009-0683-y 19562329
10. AL DeFranco MT Crowley A Finn J Hambleton SL Weinstein 1998 The role of tyrosine kinases and map kinases in LPS-induced signaling Prog Clin Biol Res 397 119 136 1:CAS:528:DyaK1cXktFaisrk%3D 9575553
11. X Deng JP Luyendyk PE Ganey RA Roth 2009 Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models Pharmacol Rev 61 262 282 10.1124/pr.109.001727 1:CAS:528:DC%2BC3cXhsVWmu7vJ 10.1124/pr.109.001727 19805476
12. Y Edling L Sivertsson TB Andersson M Porsmyr-Palmertz M Ingelman-Sundberg 2008 Pro-inflammatory response and adverse drug reactions: mechanisms of action of ximelagatran on chemokine and cytokine activation in a monocyte in vitro model Toxicol In Vitro 22 1588 1594 10.1016/j.tiv.2008.06.011 1:CAS:528:DC%2BD1cXhtVShs7fI 10.1016/j.tiv.2008.06.011 18640260
13. Y Edling LK Sivertsson A Butura M Ingelman-Sundberg M Ek 2009 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model Toxicol In Vitro 23 1387 1395 10.1016/j.tiv.2009.07.026 1:CAS:528:DC%2BD1MXht1Wmsr7E 10.1016/j.tiv.2009.07.026 19631733
14. JM English MH Cobb 2002 Pharmacological inhibitors of MAPK pathways Trends Pharmacol Sci 23 40 45 1:CAS:528:DC%2BD38Xms1emsw%3D%3D 10.1016/S0165-6147(00)01865-4 11804650 (Pubitemid 34135974)
15. PE Ganey JP Luyendyk JF Maddox RA Roth 2004 Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor Chem Biol Interact 150 35 51 10.1016/j.cbi.2004.09.002 1:CAS:528:DC%2BD2cXptFOntbw%3D 10.1016/j.cbi.2004.09.002 15522260 (Pubitemid 39441294)
16. DW Gottschall VJ Theodorides R Wang 1990 The metabolism of benzimidazole anthelmintics Parasitol Today 6 115 124 1:CAS:528:DyaK3cXksFWru7g%3D 10.1016/0169-4758(90)90228-V 15463313 (Pubitemid 20131120)
17. M Guha N Mackman 2001 LPS induction of gene expression in human monocytes Cell Signal 13 85 94 1:CAS:528:DC%2BD3MXitVOmtb0%3D 10.1016/S0898-6568(00) 00149-2 11257452 (Pubitemid 32222977)
18. M Hirosawa M Nakahara R Otosaka A Imoto T Okazaki S Takahashi 2009 The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells Leuk Res 33 693 699 10.1016/j.leukres.2008.09.028 1:CAS:528:DC%2BD1MXivVajsrw%3D 10.1016/j.leukres.2008.09.028 18995898
19. MP Holt C Ju 2006 Mechanisms of drug-induced liver injury AAPS J 8 E48 E54 10.1208/aapsj080106 1:CAS:528:DC%2BD28XjsVCisLo%3D 10.1208/aapsj080106 16584133 (Pubitemid 44603865)
20. Y Ishii S Sakai Y Honma 2001 Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells Leuk Res 25 813 820 1:CAS:528:DC%2BD3MXlslertbs%3D 10.1016/S0145-2126(01)00026-1 11489475 (Pubitemid 32727983)
21. H Jaeschke 2005 Role of inflammation in the mechanism of acetaminophen-induced hepatotoxicity Expert Opin Drug Metab Toxicol 1 389 397 10.1517/17425255.1.3.389 1:CAS:528:DC%2BD2MXhtVGjsLvO 10.1517/17425255.1.3.389 16863451
22. U Junge W Mohr 1983 Mebendazole-hepatitis Z Gastroenterol 21 736 738 1:STN:280:DyaL2c7itlemsg%3D%3D 6666188
23. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 1:CAS:528:DC%2BD3MXlsFags7s%3D 10.1038/227680a0 5432063
24. EJ Leonard T Yoshimura S Tanaka M Raffeld 1991 Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1 J Invest Dermatol 96 690 694 1:CAS:528:DyaK3MXkvFSntrs%3D 10.1111/1523-1747.ep12470612 2022877
25. S Numazawa M Watabe S Nishimura M Kurosawa M Izuno T Yoshida 2003 Regulation of ERK-mediated signal transduction by p38 MAP kinase in human monocytic THP-1 cells J Biochem 133 599 605 1:CAS:528:DC%2BD3sXlsFantbg%3D 10.1093/jb/mvg077 12801911 (Pubitemid 36759467)
26. PJ O'Brien W Irwin D Diaz E Howard-Cofield CM Krejsa MR Slaughter B Gao N Kaludercic A Angeline P Bernardi P Brain C Hougham 2006 High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Arch Toxicol 80 580 604 10.1007/s00204-006-0091-3 16598496 (Pubitemid 44214526)
27. DM Payne AJ Rossomando P Martino AK Erickson JH Her J Shabanowitz DF Hunt MJ Weber TW Sturgill 1991 Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase) EMBO J 10 885 892 1:CAS:528:DyaK3MXit1Cnu7o%3D 1849075 (Pubitemid 21905546)
28. RA Roth JP Luyendyk JF Maddox PE Ganey 2003 Inflammation and drug idiosyncrasy-is there a connection? J Pharmacol Exp Ther 307 1 8 10.1124/jpet.102.041624 1:CAS:528:DC%2BD3sXnslGkt7c%3D 10.1124/jpet.102.041624 12954806 (Pubitemid 37151885)
29. R Seitz W Schwerk R Arnold 1983 Hepatocellular drug reactions caused by mebendazole therapy in cystic echinococcosis Z Gastroenterol 21 324 329 1:STN:280:DyaL3szgsVaisw%3D%3D 6613213
30. S Tafazoli DD Spehar PJ O'Brien 2005 Oxidative stress mediated idiosyncratic drug toxicity Drug Metab Rev 37 311 325 10.1081/DMR-55227 1:CAS:528:DC%2BD2MXltlWmtLc%3D 15931767 (Pubitemid 40677507)